Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Eurekahedge Hedge Fund Index up 1.58% in April, assets gained $52bn

Wednesday, May 25, 2011
Opalesque Industry Update - Hedge funds recorded the tenth consecutive month of positive returns in April as the Eurekahedge Hedge Fund Index gained 1.58%. Most regional hedge funds ended the month with positive returns while Japanese managers delivered downside protection and outperformed their underlying market indices. The industry attracted $28.33 billion in net asset flows while performance based growth was $23.97 billion. Total assets under management increased by US$52.30 billion to cross the US$1.8 trillion mark by the end of April.

Highlights of hedge fund performance and asset flows for the month are as follows:

  • Hedge funds see tenth consecutive month of positive returns, gaining 13.48% over this period.
  • Total industry assets cross US$1.81 trillion for the first time since the financial crisis.
  • Net flows in the first four months now exceed total net flows for whole of 2010 ($93.9bn April 2011 YTD vs. $66bn in 2010).
  • CTA/managed futures funds up 3.12% in April.
  • Funds of hedge funds see first quarter of net positive asset flows since 1Q 2008.
  • Asian hedge funds witness twelve consecutive months of net positive asset flows.
  • Long/short equity funds have attracted US$30.7 billion April YTD.
  • Launch activity remains strong with more than 200 funds launched so far in the year.
  • Assets in event driven hedge funds crossed US$200 billion mark (for the first time or to reach historical highs).
  • 43% of FoHFs investors are planning to increase allocations to event driven strategies over the next 3 months...
  • ...while 34% are planning to increase their exposure to Asia ex-Japan strategies.

The full May report by Eurekahedge can be downloaded here: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for